The FDA is making several changes to the labels of statins following a comprehensive review, the agency announced on Tuesday: Incident diabetes and increased blood glucose are possible with statin use. Several meta-analyses found an increased risk for diabetes (9%–13%) in patients taking statins. Reversible memory loss and confusion are possible, though rare. The FDA said there is no evidence that...
Search This Blog
-----------------------------------------------------------------------------------------------------------------------------------------------------------------
Showing posts with label Statin Labels. Show all posts
Showing posts with label Statin Labels. Show all posts